Tags Biotechnology
Related Insights
Thu 12 Dec 2024
Prostate cancer drug discovery: promising advance
A collaboration between Kantify and Johns Hopkins School of Medicine leads to initial, promising pre-clinical results on metastatic prostate cancer
Thu 11 Jul 2024
Recap of Rexpo 2024 on AI and Repurposing
Kantify's work on AI for target and drug prediction for rare diseases highlighted at Rexpo2024
Thu 17 Aug 2023
AI and Drug Repurposing: Farewell, serendipity?
Our pledge to make therapies available for patients, faster, and why Artificial Intelligence is the key for small molecule repurposing
Fri 29 Apr 2022
ADMET prediction with Artificial Intelligence : Publication
Peer reviewed publication "Dual Blockade of Misfolded Alpha-Sarcoglycan Degradation by Bortezomib and Givinostat Combination"
Mon 14 Mar 2022
Artificial Intelligence for Targeted Protein Degradation
Discover how Kantify’s AI -based drug discovery tool, Sapian, accelerates the discovery of promising Targeted Protein Degraders (PROTAC, DUBTAC, LYTAC,...),
Thu 27 May 2021
Key AI Techniques in small molecule screening
Discover the key Artificial Intelligence techniques used for small molecule screening
Related News
Tue 06 May 2025
AI and Repurposing: Kantify's COO at iDR25
Nicolas Maignan to deliver a presentation about AI for repurposing at the International Drug Repurposing Conference 2025
Tue 19 Nov 2024
AI for plants based drug discovery: Kantify lecture at IBMCP
How can AI accelerate target discovery and small molecule discovery in plants? First lecture at IBMCP
Thu 22 Aug 2024
DREAMS: when AI finds drugs for rare diseases
Discover on the DREAMS project website how Kantify contributes to the discovery of therapeutic targets and treatments for 5 rare neuromuscular disorders
Tue 02 Apr 2024
Kantify reveals promising results in sarcoma at ESMO
Kantify Unveiled Promising Results in Liposarcoma Drug Discovery thanks to AI at ESMO Sarcoma and Rare Cancer Congress 2024
Tue 19 Mar 2024
Nicolas Maignan appointed Chief Operating Officer of Kantify
Announcement: Nicolas Maignan is officially appointed COO of Kantify
Thu 14 Mar 2024
AI for Healthcare panel at the Pharma.be General Assembly
Kantify was invited at the pharma.be special panel on AI for Healthcare
Mon 11 Dec 2023
Kantify at Belgium's Biopharmaceutical Excellence Conference
Kantify shared some of its groundbreaking work at the Conference on the Belgian biopharmaceutical sector organized by the Federal Ministry of Foreign Affairs
Thu 07 Dec 2023
Appointment of Dr Eckhard von Keutz as Scientific Advisor
Kantify appoints Dr von Keutz, former Vice-President at Bayer Pharmaceuticals, as Scientific Advisor
Thu 15 Jun 2023
Presentation at Cafes de L'Innovation
Kantify is invited to present its work on AI for target identification and small molecule prediction at Institut Bordet
Tue 06 Jun 2023
Kantify Nominated as Early Startup to Watch by Sifted
We are featured in Sifted's report "AI-Driven Drug Discovery 2.0" Market Report
Fri 03 Mar 2023
Upcoming talk: in silico drug discovery and animal testing
Kantify will present at the upcoming study "Animals and Alternatives: The Way Forward"
Tue 28 Feb 2023
When AI meets Stem Cells: spotlight on our work with I-Stem
Kantify and I-Stem work together for faster rare disease drug discovery
Mon 06 Feb 2023
Special edition on Artificial Intelligence in La Libre Eco
Kantify in the special edition of La Libre Eco on Artificial Intelligence
Sun 05 Feb 2023
Kantify' CEO interview on TV LN24
Kantify's CEO was invited as "CEO of the week" by Bruno Wattenbergh on LN24
Thu 27 Oct 2022
Belgian AI Strategy: Kantify joins State Secretary
State Secretary Mathieu Michel invited us to illustrate the power of AI in Health at UCB for the launch event of the Belgian AI plan
Mon 17 Oct 2022
Kantify & Mcule harness data to accelerate drug discovery
Kantify, using its AI technology for drug discovery and Mcule,with its compound sourcing platform, are collaborating to leverage data for better hit prediction
Tue 09 Aug 2022
Kantify in BX1 show on startups and Artificial Intelligence
Kantify was invited to the special edition of BX-1's Startup Story on Start-Ups and Artificial Intelligence
Mon 02 May 2022
Register to our webinar : Targeted Protein Degraders and AI
Discover how Artificial Intelligence can be used in the discovery and design of Targeted Protein Degraders.
Wed 27 Apr 2022
New discovery with I-Stem (Press Release)
Announcement : Kantify And I-Stem use Artificial Intelligence (AI) and Stem Cells to Discover A Promising Therapy Against A Rare Disease
Wed 13 Apr 2022
Abstract selected for Knowledge For Growth
The Abstract presents how AI can be used to accelerate and derisk lead optimization by predicting ADMET properties and off-target binding scores
Mon 28 Mar 2022
Kantify at the annual event of Brussels' Healthtech cluster
Kantify is speaking at the annual event of the Brussels cluster of healthtech companies
Tue 22 Mar 2022
Unveiling Sapian, Kantify’s AI drug discovery technology
Discover the new AI technology that accelerates small molecule and targeted protein degradation discovery
Thu 30 Sep 2021
European Biotech Week: webinar on AI for Drug Discovery
Kantify hosted its first webinar titled Artificial Intelligence for Drug Discovery and Development, as a part of the European Biotechnology Week 2021
Wed 01 Sep 2021
Kantify at the European Biotech Week: AI for Drug Discovery
Kantify is hosting a virtual event during European Biotech Week titled: Artificial Intelligence in drug discovery and development
Thu 22 Jul 2021
Kantify joins the European Biotechnology Network
Kantify has joined the European Biotechnology Network dedicated to biotechnology and life sciences
Mon 10 May 2021
Kantify joins Data-driven Advanced Therapeutics Accelerator
Kantify joins Data-driven Advanced Therapeutics Accelerator managed by Stevenage Bioscience Catalyst
Wed 14 Apr 2021
The CEO of Kantify interviews with DataNews
The CEO of Kantify speaks about her journey in AI and the potential of AI in the healthcare industry
Wed 24 Mar 2021
European Commission Report on AI Uptake in Healthcare
The European Commission publishes a report to monitor the development, uptake and impact of Artificial Intelligence for healthcare.
Tue 16 Mar 2021
Kantify at the Belgian AI Week 2021
Kantify is taking part in several events on Artificial Intelligence (AI) during the 2021 Belgian AI Week.